Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes

BACKGROUND: Onchocerciasis is targeted for elimination in Africa through annual or biannual ivermectin mass drug administration (MDA). An immunodiagnostic test, based on the detection of human IgG4 antibodies in the blood to the Onchocerca volvulus-specific antigen Ov16, is one of the recommended to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lont, Yvonne L., Coffeng, Luc E., de Vlas, Sake J., Golden, Allison, de los Santos, Tala, Domingo, Gonzalo J., Stolk, Wilma A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289624/
https://www.ncbi.nlm.nih.gov/pubmed/28114304
http://dx.doi.org/10.1371/journal.pntd.0005314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289624/
https://www.ncbi.nlm.nih.gov/pubmed/28114304
http://dx.doi.org/10.1371/journal.pntd.0005314

Ejemplares similares